From: Biomarkers and acute brain injuries: interest and limits
 | Dosage | Initial severity | GOS |  | ||||||
---|---|---|---|---|---|---|---|---|---|---|
Biomarker | CSF | Plasma | GCS | WFNS | HH | Fisher | 3Â months | 6Â months | 12Â months | Mortality |
ET-1 | + | + | Â | Â | + (CSF) | Â | Â | Â | Â | + (plasma) |
TNF-α | + | + |  |  | – CSF) |  | – (CSF) |  |  |  |
IL-6 | + |  |  |  | – |  |  | + |  |  |
IL-1β | + |  |  |  | – |  | – |  |  |  |
ICAM-1, VCAM-1 | + | + |  | – (CSF, plasma) | – (CSF, plasma) |  |  |  | – (CSF, plasma) |  |
Light-chain NF | + | Â | Â | Â | Â | Â | Â | Â | + | Â |
Heavy-chain NF | + | Â | + | + | Â | Â | + | Â | Â | Â |
ApoE | + |  | + |  |  | – | + |  |  |  |
S100β | + | + | – (CSF) | + (plasma) |  | + (plasma) | – (CSF) | + (plasma) |  |  |
ANP | Â | + | Â | Â | + (plasma) | + (plasma) | Â | Â | Â | Â |
BNP | Â | + | Â | Â | Â | + | Â | Â | Â | + |
cTnI | Â | + | + | Â | + | + | + | Â | Â | + |
vWF, MMP-9, VEGF | Â | + | Â | Â | Â | + | Â | Â | Â | Â |
CRP | + | + | + (CSF, plasma) | Â | + (CSF, plasma) | + (CSF, plasma) | + (CSF, plasma) | Â | Â | Â |